| The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35, 1271-1285, 2017 | 151 | 2017 |
| Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria L Gulácsi, AM Rotar, M Niewada, O Löblová, F Rencz, G Petrova, I Boncz, ... The European journal of health economics 15, 13-25, 2014 | 108 | 2014 |
| Patients’ perceptions of information and education for renal replacement therapy: an independent survey by the European kidney Patients' Federation on information and support … W Van Biesen, SN van der Veer, M Murphey, O Loblova, S Davies PLoS One 9 (7), e103914, 2014 | 89 | 2014 |
| When epistemic communities fail: exploring the mechanism of policy influence O Löblová Policy studies journal 46 (1), 160-189, 2018 | 58 | 2018 |
| European integration in the era of permissive dissensus: Neofunctionalism and agenda-setting in European health technology assessment and communicable disease control SL Greer, O Löblová Comparative European Politics 15, 394-413, 2017 | 43 | 2017 |
| Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe O Löblová Health Economics, Policy and Law 11 (3), 253-273, 2016 | 38 | 2016 |
| Centralizing and decentralizing governance in the COVID-19 pandemic: The politics of credit and blame SL Greer, S Rozenblum, M Falkenbach, O Löblová, H Jarman, N Williams, ... Health Policy 126 (5), 408-417, 2022 | 37 | 2022 |
| Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries AM Rotar, A Preda, O Löblová, V Benkovic, S Zawodnik, L Gulacsi, ... Health Policy 122 (3), 230-236, 2018 | 30 | 2018 |
| When health technology assessment is confidential and experts have no power: the case of Hungary M Csanádi, O Löblová, P Ozierański, A Harsányi, Z Kaló, M McKee, ... Health Economics, Policy and Law 14 (2), 162-181, 2019 | 28 | 2019 |
| Epistemic communities and experts in health policy-making O Löblová European journal of public health 28 (suppl_3), 7-10, 2018 | 28 | 2018 |
| Half a century of Wilson & Jungner: reflections on the governance of population screening S Sturdy, F Miller, S Hogarth, N Armstrong, P Chakraborty, C Cressman, ... Wellcome Open Research 5, 2020 | 25 | 2020 |
| COVID-19 in Central and Eastern Europe: Focus on Czechia, Hungary, and Bulgaria O Löblová, J Rone, E Borbáth Coronavirus Politics: The Comparative Politics and Policy of COVID-19, 2021 | 22 | 2021 |
| The emerging social science literature on health technology assessment: a narrative review O Löblová, T Trayanov, M Csanádi, P Ozierański Value in Health 23 (1), 3-9, 2020 | 22 | 2020 |
| What has health technology assessment ever done for us? O Löblová Journal of health services research & policy 23 (2), 134-136, 2018 | 19 | 2018 |
| Transparency in practice: evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015 P Ozierański, O Löblová, N Nicholls, M Csanádi, Z Kaló, M McKee, L King Health Economics, Policy and Law 14 (2), 182-204, 2019 | 15 | 2019 |
| Who’s afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic O Löblová Health Economics, Policy and Law 13 (2), 137-161, 2018 | 15 | 2018 |
| Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology O Löblová, M Csanádi, P Ozierański, Z Kaló, L King, M McKee Health Policy 123 (7), 630-634, 2019 | 14 | 2019 |
| Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016 O Löblová, M Csanádi, P Ozierański, Z Kaló, L King, M McKee Health Policy 123 (8), 713-720, 2019 | 11 | 2019 |
| Coronavirus: what went wrong in the Czech Republic? O Löblová The Conversation 9, 2020 | 9 | 2020 |
| Shedding light on the HTA consultancy market: insights from Poland M Csanádi, P Ozierański, O Löblová, L King, Z Kaló, L Botz Health Policy 123 (12), 1237-1243, 2019 | 9 | 2019 |
Piotr OzieranskiReader in Sociology, Department of Social and Policy Sciences, University of BathVerified email at bath.ac.uk
